Full Name
Wee Joo Chng
Variants
Chng W.J
Chng, W.J.
Chng W.-J.
Wee Joo Chng
Chng, W.-J.
 
 
 
Email
mdccwj@nus.edu.sg
 
 

Publications

Results 21-40 of 122 (Search time: 0.011 seconds).

Issue DateTitleAuthor(s)
211-Aug-2016Comprehensive mutational analysis of primary and relapse acute promyelocytic leukemiaMadan, V ; Shyamsunder, P ; Han, L; Mayakonda, A ; Nagata, Y; Sundaresan, J ; Kanojia, D ; Yoshida, K; Ganesan, S; Hattori, N; Fulton, N; Tan, KT ; Alpermann, T; Kuo, MC; Rostami, S; Matthews, J; Sanada, M; Liu, L-Z ; Shiraishi, Y; Miyano, S; Chendamarai, E; Hou, HA; Malnassy, G; Ma, T; Garg, M ; Ding, LW ; Sun, QY ; Chien, W ; Ikezoe, T; Lill, M; Biondi, A; Larson, RA; Powell, BL; Lubbert, M; Chng, WJ ; Tien, HF; Heuser, M; Ganser, A; Koren-Michowitz, M; Kornblau, SM; Kantarjian, HM; Nowak, D; Hofmann, WK; Yang, H ; Stock, W; Ghavamzadeh, A; Alimoghaddam, K; Haferlach, T; Ogawa, S; Shih, LY; Mathews, V; Koeffler, HP 
21-Dec-2016Comprehensive mutational analysis of primary and relapse acute promyelocytic leukemia (vol 30, pg 1672, 2016)Madan, V ; Shyamsunder, P ; Han, L; Mayakonda, A ; Nagata, Y; Sundaresan, J ; Kanojia, D ; Yoshida, K; Ganesan, S; Hattori, N; Fulton, N; Tan, KT ; Alpermann, T; Kuo, MC; Rostami, S; Matthews, J; Sanada, M; Liu, L-Z ; Shiraishi, Y; Miyano, S; Chendamarai, E; Hou, HA; Malnassy, G; Ma, T; Garg, M ; Ding, LW ; Sun, QY ; Chien, W ; Ikezoe, T; Lill, M; Biondi, A; Larson, RA; Powell, BL; Lubbert, M; Chng, WJ ; Tien, HF; Heuser, M; Ganser, A; Koren-Michowitz, M; Kornblau, SM; Kantarjian, HM; Nowak, D; Hofmann, WK; Yang, H ; Stock, W; Ghavamzadeh, A; Alimoghaddam, K; Haferlach, T; Ogawa, S; Shih, LY; Mathews, V; Koeffler, HP 
32010Correlation between array-comparative genomic hybridization-defined genomic gains and losses and survival: Identification of 1p31-32 deletion as a prognostic factor in myelomaChng, W.J. ; Van, Wier S.; Keats, J.J.; Bergsagel, P.L.; Fonseca, R.; Gertz, M.A.; Chung, T.-H. ; Baker, A.; Carpten, J.
421-Sep-2023COVID-19 Severity and Waning Immunity After up to 4 mRNA Vaccine Doses in 73 608 Patients With Cancer and 621 475 Matched Controls in Singapore A Nationwide Cohort StudyTan, Wei Chong; Tan, Janice Yu Jin; Lim, Joline Si Jing ; Tan, Ryan Ying Cong ; Lee, Ainsley Ryan Yan Bin; Leong, Fun Loon; Lee, Soo Chin ; Chai, Louis Yi Ann ; Tan, Thuan Tong ; Malek, Muhammad Ismail Bin Abdul; Ong, Benjamin ; Lye, David Chien ; Chiew, Calvin J; Chng, Wee Joo ; Lim, Soon Thye ; Bharwani, Lavina D; Tan, Iain Beehuat; Sundar, Raghav ; Tan, Kelvin Bryan
516-Oct-2021DDX3X loss is an adverse prognostic marker in diffuse large B-cell lymphoma and is associated with chemoresistance in aggressive non-Hodgkin lymphoma subtypesKizhakeyil, Atish; Zaini, Nurmahirah Binte Mohammed; Poh, Zhi Sheng; Wong, Brandon Han Siang; Loh, Xinpeng; Ng, Aik Seng; Low, Zun Siong; Prasannan, Praseetha; Gong, Chun; Tan, Michelle Guet Khim; Nagarajan, Chandramouli; Huang, Dachuan; Lu, Pang Wan; Lim, Jing Quan; Barrans, Sharon; Ong, Choon Kiat; Lim, Soon Thye; Chng, Wee Joo ; Follows, George; Hodson, Daniel J; Du, Ming Qing; Goh, Yeow Tee; Tan, Suat Hoon; Grigoropoulos, Nicholas Francis; Verma, Navin Kumar
623-Apr-2020Deepening responses associated with improved progression-free survival with ixazomib versus placebo as posttransplant maintenance in multiple myelomaGoldschmidt, Hartmut; Dimopoulos, Meletios A; Rajkumar, S Vincent; Weisel, Katja C; Moreau, Philippe; Chng, Wee-Joo ; Mikala, Gabor; Cavo, Michele; Ramasamy, Karthik; Suryanarayan, Kaveri; Teng, Zhaoyang; Labotka, Richard; Victoria Mateos, Maria
710-Jun-2020Denosumab Versus Zoledronic Acid in Bone Disease Treatment of Newly Diagnosed Multiple Myeloma: An International, Double-Blind, Randomized Controlled Phase 3 Study-Asian Subgroup AnalysisHuang, Shang-Yi; Yoon, Sung-Soo; Shimizu, Kazuyuki; Chng, Wee Joo ; Chang, Cheng-Shyong; Wong, Raymond Siu-Ming; Gao, Seasea; Wang, Yang; Gordon, Steve W; Glennane, Anthony; Min, Chang-Ki
81-Jan-2021Determinants of response to daratumumab in Epstein-Barr virus-positive natural killer and T-cell lymphomaMustafa, Nurulhuda ; Nee, Adina Huey Fang ; Chooi, Jing Yuan ; Toh, Sabrina Hui Min ; Chung, Tae-Hoon ; Selvarajan, Viknesvaran ; Fan, Shuangyi ; Ng, Siok Bian ; Poon, Michelle ; Chan, Esther ; Lee, Joanne; Chee, Yen Lin ; Jeyasekharan, Anand D ; Zhou, Longen; Yang, Jennifer; Chng, Wee Joo 
93-Nov-2011Dysregulated microRNAs affect pathways and targets of biologic relevance in nasal-type natural killer/T-cell lymphomaNg, Siok-Bian ; Yan, Junli ; Huang, Gaofeng ; Selvarajan, Viknesvaran; Tay, Jim Liang-Seah; Lin, Baohong; Bi, Chonglei; Tan, Joy; Kwong, Yok-Lam; Shimizu, Norio; Aozasa, Katsuyuki; Chng, Wee-Joo 
10Apr-2012Effect of dasatinib against thyroid cancer cell lines in vitro and a xenograft model in vivoChan, D.; Tyner, J.W.; Chng, W.J. ; Bi, C.; Okamoto, R.; Said, J.; Ngan, B.D.; Braunstein, G.D.; Koeffler, H.P. 
111-Sep-2021Effective Killing of Acute Myeloid Leukemia by TIM-3 Targeted Chimeric Antigen Receptor T CellsLee, Wen-Hsin Sandy; Ye, Zhiyong; Cheung, Alice MS; Goh, YP Sharon; Oh, Hsueh Ling Janice; Rajarethinam, Ravisankar; Yeo, Siok Ping; Soh, Mun Kuen; Li Chan, Esther Hian; Tan, Lip Kun; Tan, Soo-Yong ; Chuah, Charles ; Chng, Wee Joo ; Connolly, John E; Wang, Cheng-I
121-Feb-2012Engineering the First Chimeric Antibody in Targeting Intracellular PRL-3 Oncoprotein for Cancer Therapy in MiceGuo, Ke; Tang, Jing Ping ; Jie, Li; Al-Aidaroos, Abdul Qader O; Hong, Cheng William; Tan, Cheng Peow Bobby; Park, Jung Eun; Varghese, Leyon; Feng, Zhiwei; Zhou, Jianbiao; Chng, Wee Joo ; Zeng, Qi 
132009Enhanced activation of STAT pathways and overexpression of survivin confer resistance to FLT3 inhibitors and could be therapeutic targets in AMLZhou, J. ; Bi, C.; Janakakumara, J.V. ; Liu, S.-C.; Chng, W.-J. ; Tay, K.-G. ; Poon, L.-F. ; Xie, Z. ; Palaniyandi, S. ; Chen, C.-S. ; Yu, H. ; Glaser, K.B.; Albert, D.H.; Davidsen, S.K.
1425-Aug-2020Epigenetic silencing of long non-coding RNABM742401in multiple myeloma: impact on prognosis and myeloma disseminationLi, Zhenhai; Kumar, Shaji; Jin, Dong-Yan; Calin, George A; Chng, Wee-Joo ; Siu, Kam-Leung; Poon, Ming-Wai; Chim, Chor Sang
152019Epigenetic silencing of miR-340-5p in multiple myeloma: Mechanisms and prognostic impactLi, Z.; Wong, K.Y.; Calin, G.A.; Chng, W.-J. ; Chan, G.C.-F.; Chim, C.S.
161-Feb-2018Epstein-Barr virus-associated primary nodal T/NK-cell lymphoma shows a distinct molecular signature and copy number changesNg, Siok-Bian ; Chung, Tae-Hoon; Kato, Seiichi; Nakamura, Shigeo; Takahashi, Emiko; Ko, Young-Hyeh; Khoury, Joseph D; Yin, C Cameron; Soong, Richie; Jeyasekharan, Anand D ; Hoppe, Michal Marek; Selvarajan, Viknesvaran; Tan, Soo-Yong; Lim, Soon-Thye; Ong, Choon-Kiat ; Nairismagi, Maarja-Liisa; Maheshwari, Priyanka ; Choo, Shoa-Nian ; Fan, Shuangyi ; Lee, Chi-Kuen ; Chuang, Shih-Sung; Chng, Wee-Joo 
173-Aug-2015Epstein-Barr virus-associated T/natural killer-cell lymphoproliferative disorder in children and young adults has similar molecular signature to extranodal nasal natural killer/T-cell lymphoma but shows distinctive stem cell-like phenotypeNg, Siok-Bian ; Ohshima, Koichi; Selvarajan, Viknesvaran ; Huang, Gaofeng ; Choo, Shoa-Nian ; Miyoshi, Hiroaki; Shimizu, Norio; Reghunathan, Renji ; Chua, Hsin-Chieh ; Yeoh, Allen Eng-Juh ; Thuan-Chong, Quah ; Koh, Liang-Piu ; Tan, Poh-Lin ; Chng, Wee-Joo 
182016Exocytosis of polyubiquitinated proteins in bortezomib-resistant leukemia cells: A role for MARCKS in acquired resistance to proteasome inhibitorsFranke, N.E; Kaspers, G.L; Assaraf, Y.G; Meerloo, J; Niewerth, D; Kessler, F.L; Poddighe, P.J; Kole, J; Smeets, S.J; Ylstra, B; Bi, C; Chng, W.J ; Horton, T.M; Menezes, R.X; Musters, R.J.P; Zweegman, S; Jansen, G; Cloos, J
1916-Nov-2013Extranodal natural killer/T-cell lymphoma involving the gastrointestinal tract: Analysis of clinical features and outcomes from the Asia Lymphoma study groupKim, S.J.; Jung, H.A.; Chuang, S.-S.; Hong, H.; Guo, C.-C.; Cao, J.; Hong, X.-N.; Suzuki, R.; Kang, H.J.; Won, J.H.; Chng, W.-J. ; Kwong, Y.-L.; Suh, C.; Song, Y.-Q.; Zhu, J.; Tay, K.; Lim, S.T.; Suzumiya, J.; Lin, T.-Y.; Kim, W.S.
2018-Aug-2016EZH2 phosphorylation by JAK3 mediates a switch to noncanonical function in natural killer/T-cell lymphomaYan, Junli; Li, Boheng ; Lin, Baohong; Lee, Pei Tsung ; Chung, Tae-Hoon; Tan, Joy; Bi, Chonglei; Lee, Xue Ting ; Selvarajan, Viknesvaran; Ng, Siok-Bian ; Yang, Henry ; Yu, Qiang; Chng, Wee-Joo